FDA NDC Directory · JSON-LD · Markdown

ADMELOG

NDC 70518-4275 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin lispro
Labeler / ManufacturerREMEDYREPACK INC.
Marketing categoryBiologic License Application · App BLA209196
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN LISPRO (100 U/mL)
Marketing started20250204
Package count1

External sources

Source: openFDA. Public-domain (CC0).